The most common grade 3 or 4 adverse events were cutaneous squamous-cell carcinoma ( 12 patients , 9 % ; all grade 3 ) , raised amounts of alkaline phosphatase ( 11 patients , 9 % ] ) , and anaemia ( nine patients , 7 % ) .